Recent literature has demonstrated that, in addition to inducing the remission of diabetes in rodent models, FGF1 induces robust activation of c-Fos and pERK1/2 in the ARH and median eminence (ME), however, the neuronal phenotypes and extent of neuronal activation in the ARH are less clear (5, 7). Here, FOS is linked to diabetes mellitus.